Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Elixinol Global attracts $40 million to accelerate international growth initiatives

The company is increasing the capacity of its hemp-derived cannabidiol production facility in the US.
hemp oil
Elixinol is awaiting a medicinal cannabis license in Australia

Elixinol Global Ltd (ASX:EXL) (OTCMKTS:ELLXF) has successfully completed a share placement to domestic and international institutional and sophisticated investors raising $40 million at $1.85 per share.

The group’s portfolio comprises three main divisions: Elixinol USA focused on dietary supplements; Hemp Foods Australia selling food products; and Elixinol Australia, the new start-up focused on medicinal cannabis.

The company listed on the ASX in January this year and raised about $20 million from an oversubscribed initial public offer.

Elixinol chief executive officer Paul Benhaim said: “The global cannabis market is growing at a rapid rate and Elixinol Global recognises the need to move quickly to leverage the opportunity around the business.

“This funding ensures we can seize the market opportunities in front of us, and in doing so, propel the business toward its next phase of growth.”

 

Elixinol will apply the funds towards increasing the capacity of its hemp-derived CBD (cannabidiol) production facility in the US to prepare for increasing levels of demand.

The company will also ramp up its sales force and marketing efforts in the US and Europe.

The new funding will also provide Elixinol with additional working capital to support its growth, pursue strategic investment opportunities and construct its Australian medicinal cannabis facility, upon receipt of a medicinal cannabis license from the Office of Drug Control.

Benhaim added: “We are grateful for the support from existing and new investors who participated in this capital raising in recognition of our world-class brand that continues to drive revenue growth and profitability for Elixinol Global.”

Join our Crypto, Blockchain and Cannabis Telegram group here
View full EXL profile View Profile

Elixinol Global Ltd Timeline

Related Articles

1539364967_Cannabis-plant.jpg
October 10 2018
Management behind ICC International Cannabis Corp has a clear buy, build and sell strategy
cannabis
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use